Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ans Punt
Observed names:
A. Punt,
Punt, A.,
Punt, Ans
Institution:
Unilever (United Kingdom)
Observed institutions:
Unilever (United Kingdom),
Utrecht University,
University of Ioannina,
Nestlé (Switzerland),
KWR Water Research Institute,
Wageningen University & Research
show all 6
ORCID:
0000-0002-2056-4634
Observed ORCID:
0000-0002-2056-4634
OpenAlex ID:
A5084547667
Works
125
Awards
1
Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2
2004
·
Jelmer J. van Zanden
, Heleen M. Wortelboer
, et al.
·
Biochemical Pharmacology
·
180
Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making
2018
·
A. Paini
, J.A. Leonard
, et al.
·
Computational Toxicology
·
159
PDF
Impact of nanoparticle surface functionalization on the protein corona and cellular adhesion, uptake and transport
2018
·
Ashraf Abdelkhaliq
, Meike van der Zande
, et al.
·
Journal of Nanobiotechnology
·
123
PDF
A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat
2008
·
Ans Punt
, Andreas P. Freidig
, et al.
·
Toxicology and Applied Pharmacology
·
98
Tutorial on physiologically based kinetic modeling in molecular nutrition and food research
2011
·
Ivonne M. C. M. Rietjens
, Jochem Louisse
, et al.
·
Molecular Nutrition & Food Research
·
92
Perfluoroalkyl substances (PFASs) are substrates of the renal human organic anion transporter 4 (OAT4)
2022
·
Jochem Louisse
, Luca Dellafiora
, et al.
·
Archives of Toxicology
·
88
PDF
Use of Physiologically Based Biokinetic (PBBK) Modeling to Study Estragole Bioactivation and Detoxification in Humans as Compared with Male Rats
2009
·
Ans Punt
, Alicia Paini
, et al.
·
Toxicological Sciences
·
87
PDF
Human Cytochrome P450 Enzyme Specificity for the Bioactivation of Estragole and Related Alkenylbenzenes
2007
·
Suzanne M. F. Jeurissen
, Ans Punt
, et al.
·
Chemical Research in Toxicology
·
86
Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose–response curves for developmental toxicity of phenol in rat and human
2013
·
Marije Strikwold
, Bert Spenkelink
, et al.
·
Archives of Toxicology
·
84
A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes
2010
·
Alicia Paini
, Ans Punt
, et al.
·
Toxicology and Applied Pharmacology
·
77
Development of a Web-Based Toolbox to Support Quantitative In-Vitro-to-In-Vivo Extrapolations (QIVIVE) within Nonanimal Testing Strategies
2020
·
Ans Punt
, Nicole Pinckaers
, et al.
·
Chemical Research in Toxicology
·
73
PDF
New approach methodologies (NAMs) for human-relevant biokinetics predictions
2020
·
Ans Punt
·
ALTEX
·
69
PDF
Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols
2016
·
Marije Strikwold
, Bert Spenkelink
, et al.
·
Archives of Toxicology
·
69
PDF
Tandem Mass Spectrometry Analysis of N2-(trans-Isoestragol-3‘-yl)-2‘-deoxyguanosine as a Strategy to Study Species Differences in Sulfotransferase Conversion of the Proximate Carcinogen 1‘-Hydroxyestragole
2007
·
Ans Punt
, Thierry Delatour
, et al.
·
Chemical Research in Toxicology
·
69
Basil extract inhibits the sulfotransferase mediated formation of DNA adducts of the procarcinogen 1′-hydroxyestragole by rat and human liver S9 homogenates and in HepG2 human hepatoma cells
2008
·
Suzanne M.F. Jeurissen
, Ans Punt
, et al.
·
Food and Chemical Toxicology
·
66
Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect
2010
·
W. Alhusainy
, A. Paini
, et al.
·
Toxicology and Applied Pharmacology
·
64
Conversion of major soy isoflavone glucosides and aglycones in in vitro intestinal models
2013
·
Mohammed A. Islam
, Ans Punt
, et al.
·
Molecular Nutrition & Food Research
·
63
PDF
Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I
2016
·
Rozaini Abdullah
, Wasma Alhusainy
, et al.
·
Food and Chemical Toxicology
·
59
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
2022
·
Abdulkarim Najjar
, Ans Punt
, et al.
·
Archives of Toxicology
·
53
PDF
Physiologically Based Kinetic Models for the Alkenylbenzene Elemicin in Rat and Human and Possible Implications for Risk Assessment
2012
·
Suzanne J. P. L. van den Berg
, Ans Punt
, et al.
·
Chemical Research in Toxicology
·
50
Non-animal approaches for toxicokinetics in risk evaluations of food chemicals
2017
·
Ans Punt
·
ALTEX
·
48
PDF
Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practice
2011
·
Ans Punt
, Marie-Jeanne W.A. Schiffelers
, et al.
·
Regulatory Toxicology and Pharmacology
·
48
Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat
2010
·
Ala′ A.A. Al-Subeihi
, Bert Spenkelink
, et al.
·
Toxicology in Vitro
·
47
Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat
2012
·
Ala' A.A. Al-Subeihi
, Bert Spenkelink
, et al.
·
Toxicology and Applied Pharmacology
·
46
In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: Implications for risk assessment
2009
·
Ivonne M. C. M. Rietjens
, Ans Punt
, et al.
·
Molecular Nutrition & Food Research
·
43
Show more works
View as search
Works count:
125
Citation count:
2,986
H-index:
35
I10-index:
63
Year
Topic
Type
